Advances in ISSN: 2378-3168AOWMC

Obesity, Weight Management & Control
Mini Review
Volume 6 Issue 3 - 2017
Vitamin D and Sarcopenia
Behnaz Abiri1 and Mohammad Reza Vafa2*
1Department of Nutrition, Ahvaz Jundishapur University of Medical Sciences, Iran
2Department of Nutrition, Iran University of Medical Sciences, Iran
Received: January 01, 2017 | Published: February 16, 2017
*Corresponding author: Mohammad Reza Vafa, Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran, Email:
Citation: Abiri B, Vafa MR (2017) Vitamin D and Sarcopenia. Adv Obes Weight Manag Control 6(3): 00155. DOI: 10.15406/aowmc.2017.06.00155


The human body is subjected to considerable changes during the aging process. One important alteration is the progressive loss of muscle mass and function, muscle strength and performance [1] after the fifth decade of life [2], known as sarcopenia. The functional limitations and flaws due to sarcopenia decrease quality of life, compromise functional independence during senescence [2], and resulting to significant reductions in physical functions, metabolic impairments, and disability [3]. Decreased muscle strength has also been related to mortality in older adults [4]. Although numerous mechanisms have been suggested, the factors leading to sarcopenia are unclear and mostly multifactorial, include of hormonal, neurological, nutritional, environmental, and genetic factors, and their interactions [3]. One environmental agent associated with age-related losses in muscle function is vitamin D level. Low levels of vitamin D related to muscle weakness and atrophy of type ӀӀ fibers [3].

Vitamin D is a fat-soluble vitamin, and has an essential role in calcium homeostasis and keeping of normal bone metabolism [5]. Data suggest that vitamin D status is crucial for the normal function of different organs, such as pancreatic β-cells, vascular endothelial cells, neurons, immune cells, osteoblasts, and myocytes, where vitamin D receptors are expressed [5]. In addition, vitamin D deficiency is related to loss of skeletal muscle mass and function [6] and high risk of falls in older adults [6], although some researchers have shown conflicting findings [7]. Vitamin D deficiency is common in elderly population; because of reduced exposure to sun light, low intake of oral vitamin D, intestinal malabsorption, and decreased vitamin D hydroxylase activity in the kidneys [8]. The prevalence of vitamin D deficiency elevates with age, reaching about 70% in older Caucasians and Asians [6]. In addition, the effects of low vitamin D levels can be reinforced in older adults, because expression of skeletal muscle vitamin D receptor reduces with age [6]. Clinical studies about vitamin D deficiency resulted from various causes have demonstrated that beside the (bone) pain, and symptoms related to the deficiency, muscular weakness is commonly found in these patients, with incidences up to 97% [8]. Low serum 25-hydroxyvitamin D levels were associated with an elevated risk of sarcopenia in older adults, regardless of obesity, in both cross-sectional and prospective studies [9,10].

With the recognition of vitamin D receptor in muscle cells and neuronal cells,studies in cell culture and experimental animals proposed that vitamin D impacts on muscle growth, development and contraction [11]. A number of observational studies have demonstrated an association between serum 25-hydroxyvitamin D levels and measures of muscle performance [12-17] and appendicular muscle mass [12,15] in community-dwelling older adults. Furthermore, several recent randomized controlled trials of vitamin D supplementation show beneficial effects on muscle strength and physical performance in older adults with low vitamin D levels [18-21].

Vitamin D, Muscle Strength and Body Composition

A prospective study in elderly population aged 55-85 years, have shown that persons with 25(OH)-D concentration less than 25 nmol/L and high PTH concentration (4.0+ pmol/Liter) were 2.51 times more probable to experience loss of grip strength and 2.38 times more probable to experience loss of appendicular skeletal muscle mass, in comparison with persons with a low Parathyroid Hormone (PTH) and a high 25(OH)-D level [22]. Kenny et al. [23] in a randomized trial involving sixty-five healthy older men aged 65-87 years, demonstrated that vitamin D3 1000 IU plus calcium 500 mg daily, compared with the calcium alone, did not elevate muscle strength or ameliorate physical performance over a 6 months period [23]. Therefore, these data raise the probability that vitamin D status is more commonly related to muscle performance in women rather than men. Causes for this sex differences are uncertain, but potential explanations may include of differences in baseline lean body mass, muscle strength, physical activity and levels of testosterone, that is an anabolic hormone to muscle [11]. The results of the study [24] to investigate the association between 25(OH)-D concentration and percentage body fat content in 410 healthy women between 20 and 80 years, showed that percentage body fat content is inversely associated with the serum 25(OH)-D levels in healthy women. Evidence has been shown that obesity could be related to lower levels of serum 25(OH)-D [25] and higher serum PTH levels [25]. Vitamin D status is an important determinant of serum PTH concentrations, and elevated PTH enhances calcium influx into the adipocytes. In these cells, intracellular calcium promotes lipogenesis and thus, PTH surplus may enhance weight gain [25]. In a population based-study in older men and women (aged 65 yr and older) have demonstrated that total body fat is inversely related to 25(OH)-D levels and is positively related to PTH levels [25]. Another study [2] assessed the association of serum 25(OH)-D and PTH levels with skeletal muscle mass and strength (handgrip force and isometric knee extension moment), and found no consistent relationship between 25(OH)-D or PTH and any of quantification of muscle mass or strength, in either men or women. The findings of this study are similar to some cross-sectional studies [26,27], but not to others [12-17].

In a randomized controlled trial [18], 242 healthy ambulatory women and men 70 years or older with serum 25(OH)-D level below 78 nmol/L were recruited, and administered 1000 mg of calcium plus 400 IU of vitamin D or 1000 mg of calcium alone, for 12 months. Results of this study showed a decrease in the number of persons with first falls, improvement in quadriceps strength of 8%, a reduce in body sway of 28%, and a reduced in time required to perform the TUG (Timed-Up-and-Go) test of 11%. In our study [28], with the aim of investigation the effect of vitamin D supplementation (1000 IU, daily, for 3 months) on muscle strength, muscle function and body composition in healthy vitamin D-deficient middle aged-women (40-55 yr), results of the intervention showed improvement in muscle function (a reduced in time needed to perform the TGUG (Time Get Up and Go) test in vitamin D group compared with the placebo group, and also fat mass content significantly decreased in the vitamin D group at the end of the week 12, but changes did not reach significant compared with the control group. But muscle strength (handgrip strength and knee extension strength) did not differ significantly after 12 weeks.

However, methodologies differed widely among these studies, for example one of the important reasons has led to different results when attempting to clarify the relationship between vitamin D and muscle strength includes testing methods. Handgrip strength was one of the most common indicators for muscle strength but different equipment was used on different muscle groups to complete these measurements and probably result to different outcomes. Also, Low levels of vitamin D related to muscle weakness and atrophy of type ӀӀ fibers [3]; type ӀӀ fibers are fast twitch and contribute to high intensity but short duration activities [29]. In addition, there are several vitamin D polymorphisms, which are resulted from variations in DNA sequence of vitamin D receptor gene, that are associated with a variety of biological characteristics including muscle strength [29]. Moreover, in these studies, latitude, or other environmental agents that contributed to these differences is unclear.

Furthermore, cross-sectional design could not explain the causality of vitamin D and sarcopenia. It is feasible that sarcopenia results to low vitamin D status. Firstly, sarcopenia has confirmed to be an important predictor of disability and mortality in elderly population [24]. Decreased physical activity and less time spent outdoors results to vitamin D insufficiency [28]. Secondly, sarcopenia is mainly observed in obese subjects, who reveal significant muscle loss and increased fat mass [30]. Promoted body fat mass leads to vitamin D trapping in the adipose tissue, and declines the serum level of vitamin D [24]. Third, sarcopenia is related to aging [30]. Old age is a major risk factor for vitamin D insufficiency[8].

Mechanisms of Vitamin D Activity in Muscle

The genomic impact of vitamin D on muscle includes changes in mRNA that will cause de novo protein synthesis that control cell proliferation and induction of terminal differentiation [31]. In addition, the non-genomic impact of vitamin D on muscle includes the activation of protein kinase C (PKC) and Ca releasing into the cytosol [31]. Thus, this effect leads to the active transportation of Ca into the sarcoplasmic reticulum by Ca-ATPase elevating the calcium pool which is necessary for muscle contraction. Moreover, the activation of PKC has an impact on protein synthesis in the muscle cells [31].

On other hand, because inflammation is a potential risk factor for sarcopenia, the anti-inflammatory impacts of vitamin D could lead to the improvements in skeletal muscle composition [6].

Vitamin D, Gait, and Balance in Elderly Population

Few studies have been conducted to investigate the effects of vitamin D on balance and gait performance. In this regard, supplementation with vitamin D plus calcium compared with calcium alone ameliorate body sway by 9% within two months in elderly ambulatory women and similarly, vitamin D plus calcium compared with calcium alone elevated musculoskeletal function by 4-11% in institutionalized aged women [32]. The cellular effect of vitamin D on muscle was shown in one study that three months of treatment with vitamin D enhanced the number and size of type ӀӀ muscle fibers of aged women [33].

Vitamin D and Falls

In the Longitudinal Study Amesterdam, low 25(OH)-D levels (less than 25 nmol/L) were related to an increased risk of repeated falling through the following year, particularly in individuals under 75 years of age [34]. In a randomized, controlled trial, was shown that supplementation with vitamin D3 and calcium (800 IU and 1200 mg per day) for 3 months decreased the risk of falls around 49% in comparison to calcium alone [35]. Similarly in an Australian study, supplementation with vitamin D2 (at the beginning 10000 IU per week then 1000 IU per day) plus calcium (600 mg per day) for 24 months decreased the risk of falls by 30% compared to calcium alone [36]. More evidence about the effect of vitamin D supplementation on muscle is found in a meta-analysis of five randomized controlled trials, involving over 1200 ambulatory and institutionalized persons. In this analysis, vitamin D supplementation decreased the risk of falling around 22% [37].

The relationship between serum 25(OH)-D level and falls is mediated partially by physical performance [30]. This shows that low vitamin D level plays a role in the risk of falling in the aging through an impact on muscle function [30].


In conclusion, the prevalence of vitamin D deficiency elevates with age and because the elderly population has had an increasing trend during the last century, and also according to importance of vitamin D for the normal function of different organs and particularly, benefits of vitamin D in this aged group, there is rationality for the supplementation of vitamin D during the aging in order to improvement in muscle mass and performance, public’s health status and quality of life.


  1. Tanimoto Y, Watanabe M, Sun W, Sugiura Y, Tsuda Y, et al. (2012) Association between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in Japan. Arch Geront Geriatr 55(2): e9-e13.
  2. Kim JS, Wilson JM, Lee SR (2010) Dietary implications on mechanisms of sarcopenia: roles of protein, amino acids and antioxidants. Journal of Nutr Biochem 21(1): 1-13.
  3. Roth SM, Zmuda JM, Cauley JA, Shea PR, Ferrell RE (2004) Vitamin D Receptor Genotype Is Associated With Fat-Free Mass and Sarcopenia in Elderly Men. J Geront ABiol sci 59(1): 10-15.
  4. Rantanen T, Harris T, Leveille SG, Visser M, Foley D, et al. (2000) Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol Med Sci 55(3): M168-M173.
  5. Park S, Ham JO, Lee BK (2014) A positive association of vitamin D deficiency and sarcopenia in 50 year old women, but not men. Clinical Nutrition 33: e900-e905.
  6. Seo JA, Cho H, Eun CR, Yoo HJ, Kim SG, et al. (2012) Association Between Visceral Obesity and Sarcopenia and Vitamin D Deficiency in Older Koreans: The Ansan Geriatric Study. J Am Geriatr Soc 60(4): 700-706.
  7. Annweiler C, Schott AM, Berrut G, Fantino B, Beauchet O (2009) Vitamin D-related changes in physical performance: A systematic review. J Nutr Health Aging 13(10): 893-898.
  8. Verhaar HJJ, Samson MM, Jansen PAF, Vreede PL de, Manten JW, et al. (2000) Muscle strength, functional mobility and vitamin D in older women. Aging Clin Exp Res 12(6): 455-460.
  9. Haroon M, FitzGerald O (2012) Vitamin D deficiency: subclinical and clinical consequences on musculoskeletal health. Curr Rheumatol Rep 14(3): 286-293.
  10. Scott D, Blizzard L, Fell J, Ding C, Winzenberg T, et al. (2010) A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults. Clin Endocrinol (Oxf) 73: 581-587.
  11. Ceglia L, Chiu GR, Harris SS, Araujo AB (2011) Serum 25-hydroxyvitamin D concentration and physical function in adult men. Clinical Endocrinology 74(3): 370-376.
  12. Stewart JW, Alekel DL, Ritland LM, Van Loan M, Gertz E, et al. (2009) Serum 25- hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women. Menopause 16(6): 1093-1101.
  13. Kuchuk NO, Pluijm SM, Van Schoor NM, CWN Looman, JH Smit, et al. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. Journal of Clinical Endocrinology and Metabolism 94(4): 1244-1250.
  14. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, et al. (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 80(3): 752-758.
  15. Visser M, Deeg D, Lips P (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88(12): 5766-5772.
  16. Wicherts IS, Van Schoor NM, Boeke AJ, Visser M, Deeg DJ, et al. (2007) Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 92(6): 2058-2065.
  17. Pfeifer M, Begerow B, Minne HW, Schlotthauer T, Pospeschill M, et al. (2001) Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes 109(2): 87-92.
  18. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner Pammer A, et al. (2009) Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporosis International 20(2): 315-322.
  19. Dhesi JK, Jackson SH, Bearne LM, Moniz C, Hurley MV, et al. (2004) Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 33: 589-595.
  20. Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovascular Dis 20(3): 187-192.
  21. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, et al. (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18(2): 343-351.
  22. Visser M, Deeg DJ, Lips P (2003) Low Vitamin D and High Parathyroid Hormone Levels as Determinants of Loss of Muscle Strength and Muscle Mass (Sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88(12): 5766-5772.
  23. Kenny AM, Biskup B, Robbins B, Marcella G, Burleson JA (2003) Effects of vitamin D supplementation on strength, physical function and health perception in older, community-dwelling men. J Am Geriatr Soc 51(12): 1762-1767.
  24. Arunabh S, Pollack S, Yeh J, Aloia JF (2003) Body Fat Content and 25-Hydroxyvitamin D Levels in Healthy Women. J Clin Endocrinol Metab 88(1): 157-161.
  25. Snijder MB, Van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM, et al. (2005) Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study in Older Men and Women. J Clin Endocrinol Metab 90(7): 4119-4123.
  26. Gilsanz V, Kremer A, Mo AO, Wren TA, Kremer R (2010) Vitamin D status and its relation to muscle mass and muscle fat in young women. J Clin Endocrinol Metab 95(4): 1595-1601.
  27. Annweiler C, Beauchet O, Berrut G, Fantino B, Bonnefoy M, et al. (2009) Is there an association between serum 25- hydroxyvitamin D concentration and muscle strength among older women? Results from baseline assessment of the EPIDOS study. J Nutr Health Aging 13(2): 90-95.
  28. Abiri B, Vafa MR, Dehghani M, Moslehi N, Sarrafzadeh J (2016) Effect of Vitamin D Supplement Consumption on Muscle Strength, Muscle Function and Body Composition in Vitamin D-deficient Middle-aged Women: A Randomized Clinical Trial. Nutr Food Sci Res 3(3): 17-24.
  29. Ceglia L (2008) Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 29(6): 407-414.
  30. Kim MK, Baek KH, Song KH, Kang M, Park CY, Lee WY, et al. (2011) Vitamin D Deficiency Is Associated with Sarcopenia in Older Koreans, Regardless of Obesity: The Fourth Korea National Health and Nutrition Examination Surveys (KNHANES IV) 2009. J Clin Endocrinol Metab 96(10): 3250-3256.
  31. Montero Odasso M, Duque G (2005) Vitamin D in the aging musculoskeletal system: An authentic strength preserving hormone. Mol Aspects Med 26(3): 203-219.
  32. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, et al. (2000) Effects of a shorterm vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15(6): 1113-1118.
  33. Sorensen OH, Lund B, Saltin B, Lund B, Andersen RB, et al. (1979) Myopathy in bone loss of ageing: Improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) 56(2): 157-161.
  34. Snijder MB, Van Schoor NM, Pluijm SM, Van Dam RM, Visser M, et al. (2006) Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91(8): 2980-2985.
  35. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, et al. (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18(2): 343-351.
  36. Flicker L, MacInnis RJ, Stein MS, Scherer SC, Mead KE, et al. (2005) Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 53(11): 1881-1888.
  37. Bischoff Ferrari HA, Dawson Hughes B, Willett WC, Staehelin HB, Bazemore MG, et al. (2004) Effect of Vitamin D on falls: a meta-analysis. Jama 291(16): 1999-2006.
Media Partner & Supporters of AOWMC

Scholar Awards

At MedCrave we believe that knowledge should be shared. We also believe that   Read more...

Paper of the Year

In regard to the novelty and excellence of the manuscript MedCrave Group (MCG)   Read more...

Financial Support

MedCrave loves to recognize all the outstanding services delivered in the realms   Read more...


MedCrave accelerates the advancement of scientific research by convening   Read more...

MedCrave Reprints

MedCrave Group is ardent to provide article reprints at an instant affordable Read more...

© 2014-2017 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy